China Pharma Holdings (CPHI) Accumulated Expenses (2010 - 2026)
China Pharma Holdings' Accumulated Expenses was $500,160 in Q2 2026, up 161.5% from $191,293 a year earlier and up 60.6% from the prior quarter.
Powered by 
Analysis
China Pharma Holdings (CPHI) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at China Pharma Holdings came in at $350,643, up 41.9% from FY2024.
- Accumulated Expenses shows a five-year compound annual growth rate of 14.6% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $247,159 in FY2024 (-17.3%), $298,829 in FY2023 (-26.2%), $404,807 in FY2022 (+35.6%) and $298,452 in FY2021 (+68.3%).
- The Q2 2026 figure marks the highest quarterly Accumulated Expenses in data going back to Q4 2010.
- Compared with a year earlier, Accumulated Expenses has increased for four straight quarters, with growth averaging 47.8% over the last eight quarters.
- The best year-over-year quarter for Accumulated Expenses over five years was Q2 2026 (growth of 161.5%); the worst was Q2 2022 (a decline of 66.8%).
- Per Business Quant data, CPHI's Accumulated Expenses in the three quarters before Q2 2026 was $311,336 (Q1 2026), $350,643 (Q4 2025) and $170,426 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | China Pharma Holdings | 27.15 Mn | 26.03 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 500,160.00 |
| Mar 31, 2026 | 311,336.00 |
| Dec 31, 2025 | 350,643.00 |
| Sep 30, 2025 | 170,426.00 |
| Jun 30, 2025 | 191,293.00 |
| Mar 31, 2025 | 195,264.00 |
| Dec 31, 2024 | 247,159.00 |
| Sep 30, 2024 | 82,613.00 |
| Jun 30, 2024 | 208,831.00 |
| Mar 31, 2024 | 114,636.00 |
| Dec 31, 2023 | 298,829.00 |
| Sep 30, 2023 | 119,669.00 |
| Jun 30, 2023 | 120,563.00 |
| Mar 31, 2023 | 113,750.00 |
| Dec 31, 2022 | 404,807.00 |
| Sep 30, 2022 | 126,519.00 |
| Jun 30, 2022 | 110,387.00 |
| Mar 31, 2022 | 138,221.00 |
| Dec 31, 2021 | 298,452.00 |
| Sep 30, 2021 | 227,416.00 |
API Access
China Pharma Holdings Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CPHI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();